Evolus Inc (EOLS) is near the top in its industry group according to InvestorsObserver. EOLS gets an overall rating of 74. That means it scores higher than 74 percent of stocks. Evolus Inc gets a 96 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 92 out of 148 industries.
EOLS has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on EOLS!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 74 means the stock is more attractive than 74 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Evolus Inc Stock Today?
Evolus Inc (EOLS) stock is trading at $13.80 as of 12:21 PM on Monday, Apr 1, a loss of -$0.20, or -1.46% from the previous closing price of $14.00. The stock has traded between $13.70 and $14.06 so far today. Volume today is light. So far 112,899 shares have traded compared to average volume of 674,774 shares.
Click Here to get the full Stock Report for Evolus Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
